Primary FDA-Approved Indications
Use ampicillin with gentamicin for empiric neonatal coverage, continue for confirmed Listeria/Enterococcus, and employ oral formulations selectively for step-down therapy when susceptibility is proven.
Early-onset neonatal sepsis / meningitis
FDA ApprovedCombine with gentamicin; dose per gestational/postnatal age (e.g., 50–100 mg/kg/dose q8–12h). Adjust interval in renal immaturity.
Treatment Duration
Standard: 7–10 days (sepsis) (Range: 14–21 days (meningitis))
Evidence Sources
Listeria monocytogenes meningitis or bacteremia
FDA ApprovedAmpicillin plus gentamicin provides synergistic killing. Monitor renal function and serum levels if therapy is prolonged.
Treatment Duration
Standard: 14–21 days
Evidence Sources
Enterococcus faecalis infections (endocarditis, osteoarticular)
FDA ApprovedAmpicillin plus gentamicin is recommended for synergy; consider ampicillin plus ceftriaxone if gentamicin toxicity risk.
Treatment Duration
Standard: 4–6 weeks in endocarditis